Cargando…
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
SIMPLE SUMMARY: As one of the most lethal human cancers, glioblastoma treatment is a real challenge because of several resistance mechanisms, including limited drug entry into the central nervous system through the blood–brain barrier and the vast heterogeneity of this family of tumors. In the devel...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563739/ https://www.ncbi.nlm.nih.gov/pubmed/36230883 http://dx.doi.org/10.3390/cancers14194960 |